Insmed Incorporated
Insmed Incorporated（INSM）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
insm · 股价预测 · 35 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 35 位华尔街分析师
Buy
35 位分析师
共识
评级分布
12 个月目标价
High
$269
Consensus
$210
+124.9% upside
Low
$160
Median: $212 · Last Close: $93.44
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$210.18
124.9% upside
High Target
$269
187.9%
Low Target
$160
71.2%
Current Price
$93.44
as of today
Based on analyst price targets, the INSM stock price prediction for the next 12 months ranges from $160 to $269. The consensus INSM price forecast of $210.18 implies 124.9% upside from the current price of $93.44.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $88.76 | ↓ 5.00% |
1-day model range: $87.58–$89.95. Peak: $89.95 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $136 | +45.5% |
| 2028 | $176 | +88.5% |
| 2029 | $210 | +124.8% |
| 2030 | $236 | +152.9% |
| 2031 | — | +173.4% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · INSM · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-05 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-14 | Truist Securities | Maintains | Buy→Buy |
| 2026-05-08 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-05-08 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-08 | Guggenheim | Maintains | Buy→Buy |
| 2026-04-17 | Roth Capital | Maintains | Buy→Buy |
| 2026-04-14 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-04-01 | Barclays | Maintains | Overweight→Overweight |
| 2026-03-30 | Morgan Stanley | Upgrade ↑ | Equal Weight→Overweight |
| 2026-03-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Insmed Incorporated (INSM) stock. Of the recent 205 rating actions, 5 were upgrades and 4 were downgrades. 35 analysts currently cover INSM.
分析师推荐趋势
INSM analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1.7B
↓ 56.1% YoY
Revenue Next Year
$2.8B
↑ 64.8% YoY
EPS This Year
$-2.79
EPS Next Year
$0.49
↓ 117.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast INSM EPS of $-2.79 for the current fiscal year, based on estimates from 15 analysts. The INSM revenue forecast is $1.7B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
INSM 股价预测由两类独立数据源支撑：来自 35 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。INSM 的共识目标价为 $210.18（+124.9% 上行空间），分析师共识为 Buy。
INSM 的短期预测（明日）为 $88.76（-5.00%）。 INSM 对 2027 年的股价预测均值为 $136。 INSM 对 2030 年的预测区间为 $210–$263。
Insmed Incorporated 在 NASDAQ 上市，代码 INSM。INSM 在 2027 年的整体展望偏积极，在覆盖分析师中约 94% 对应 Buy 共识。
常见问题
INSM 预测 · 8 个问题根据 35 位华尔街分析师，INSM 的 12 个月平均目标价为 $210.18，最高 $269.00、最低 $160.00。若有图表，中位目标价可在上方查看。相对当前价 $93.44，隐含约 +124.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.